IMPAACT 2047; Phase II, Randomized Study of the Pharmacokinetics, Safety and Tolerability of High Dose Rifapentine given with Moxifloxacin for Tuberculosis during Pregnancy. Radiant-Moms Plus: Rifapentine in High Doses in Pregnancy with TB Grant uri icon

Overview

date/time interval

  • December 1, 2024 - November 30, 2027

sponsor award ID

  • UM1 AI068632

Affiliation